Results 101 to 110 of about 11,390 (207)
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial [PDF]
, 2016 Introduction: Diabetes mellitus affects 9% of the European population and accounts for 15% of healthcare expenditure, in particular, due to excess costs related to complications.
Beige, Joachim +14 more
core +4 more sources
International Journal of Biological Sciences, 2011 Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases.
Vijayakumar Sukumaran, Kenichi Watanabe, Punniyakoti T. Veeraveedu, Narasimman Gurusamy, Meilei Ma, Rajarajan A. Thandavarayan, Arun Prasath Lakshmanan, Ken'ichi Yamaguchi, Kenji Suzuki, Makoto Kodama
doaj
Severe Hepatitis Complicating Olmesartan Enteropathy: A Case Report
Case Reports in GastroenterologyIntroduction: Olmesartan, an angiotensin II receptor antagonist, is associated with an uncommon complication of enteropathy that presents insidiously, usually months to years after initial commencement of anti-hypertensive therapy which can be dose ...
Ruyi Tan +5 more
doaj +1 more source
ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY
Российский кардиологический журнал, 2011 We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade.
H. Yokoyama +5 more
doaj
Vascular Health and Risk Management, 2008 Luis M RuilopeUnidad de Hipertensión, Hospital 12 de Octubre, Madrid, SpainAbstract: Hypertension is a major risk factor for cardiovascular disease that contributes to the premature death of millions of people each year, and identification and ...
Luis M Ruilope
doaj
Premium policy? Getting better value from the PBS [PDF]
Overview: Poor implementation of a policy to get better value for PBS spending is costing government $320 million a year and raising questions about pharmaceutical industry involvement in drug pricing. The therapeutic group premium policy, introduced in
Peter Breadon, Stephen Duckett
core
Российский кардиологический журнал, 2012 The pharmacoeconomic analysis compared the strategies of arterial hypertension (AH) management using different angiotensin II receptor blockers (ARB). The first stage of the analysis included the cost-effectiveness modelling in patients with moderate AH ...
S. G. Gorokhova, V. V. Ryazhenov
doaj
Российский кардиологический журнал, 2010 The aim of the present work was to review published studies, investigating the dose-related efficacy on blood pressure (BP) of olmesartan and of other commercially available angiotensin II type I receptor blockers (ARBs).
Faiez Zannad, Renaud Fay
doaj
Toxicodermias por Antihipertensivos Antagonistas de los Receptores de la Angiotensina II. Revisión bibliográfica [PDF]
, 2019 La hipertensión arterial (HTA) afecta en España a más de la mitad de la población mayor de 55 años. La prevención primaria o modificación del estilo de vida conforma la base de la pirámide en el abordaje de la hipertensión arterial.
Tapia Lirio, Nayara
core
Differential involvement of hippocampal angiotensin 1 receptors in learning and memory processes in bulbectomized rats [PDF]
, 2016 There is conflicting evidence regarding the effect of AT1 receptor antagonists on learning and memory processes. The effects of angiotensin II and losartan administration into CA1 hippocampal area on the avoidance performance in olfactory bulbectomized ...
Belcheva, Iren +3 more
core +1 more source